About Prosonix
Prosonix is a company based in Oxford (United Kingdom) founded in 2006 was acquired by Circassia Pharmaceuticals in May 2015.. Prosonix has raised $27.05 million across 2 funding rounds from investors including Circassia Pharmaceuticals, Gimv and Quest for Growth. The company has 32 employees as of December 31, 2021. Prosonix operates in a competitive market with competitors including aTyr Pharma, ReCode Therapeutics, GEn1E, Enterprise Therapeutics and Ikaria, among others.
- Headquarter Oxford, United Kingdom
- Employees 32 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Circassia Limited
-
Annual Revenue
$17.94 M (USD)0as on Dec 31, 2020
-
Net Profit
$-11.66 M (USD)0as on Dec 31, 2020
-
EBITDA
-
Total Equity Funding
$27.05 M (USD)
in 2 rounds
-
Latest Funding Round
$27.05 M (USD), Series B
May 21, 2012
-
Investors
Circassia Pharmaceuticals
& 6 more
-
Employee Count
32
as on Dec 31, 2021
-
Acquired by
Circassia Pharmaceuticals
(May 18, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Prosonix
Prosonix has successfully raised a total of $27.05M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $27.05 million completed in May 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $27.0M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2012 | Amount | Series B - Prosonix | Valuation |
investors |
|
| Dec, 2007 | Amount | Series A - Prosonix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Prosonix
Prosonix has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Circassia Pharmaceuticals, Gimv and Quest for Growth. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm
|
Founded Year | Domain | Location | |
|
Tech & life science focused stage agnostic VC firm investing primarily in Western Europe
|
Founded Year | Domain | Location | |
|
Growth-stage life sciences and tech companies in Europe are funded.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Prosonix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Prosonix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Prosonix Comparisons
Competitors of Prosonix
Prosonix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as aTyr Pharma, ReCode Therapeutics, GEn1E, Enterprise Therapeutics and Ikaria, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Protein biologics are developed for treating rare diseases.
|
|
| domain | founded_year | HQ Location |
Precision medicines for lung-related diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of inflammatory and rare diseases
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of respiratory diseases such as cystic fibrosis
|
|
| domain | founded_year | HQ Location |
Therapies for respiratory-related cardiopulmonary disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of respiratory diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Prosonix
When was Prosonix founded?
Prosonix was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Where is Prosonix located?
Prosonix is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Is Prosonix a funded company?
Prosonix is a funded company, having raised a total of $27.05M across 2 funding rounds to date.
How many employees does Prosonix have?
As of Dec 31, 2021, the latest employee count at Prosonix is 32.
What is the annual revenue of Prosonix?
Annual revenue of Prosonix is $17.94M as on Dec 31, 2020.
What does Prosonix do?
Prosonix is a speciality pharmaceutical company developing a portfolio of inhaled respiratory medicines by design. Pipeline include: PSX1001PSX1050, a potent inhaled corticosteroid monotherapy for asthma and chronic obstructive pulmonary disease (COPD) in pressurised metered dose inhaler (pMDI); PSX1002, a long-acting muscarinic antagonist for COPD in pMDI; PSX2005 for asthma, SX2000 Novel combination medicines designed specifically for respiratory diseases based on Multi-component Particles (MCPs).
Who are the top competitors of Prosonix?
Prosonix's top competitors include aTyr Pharma, ReCode Therapeutics and Pulmatrix.
Who are Prosonix's investors?
Prosonix has 7 investors. Key investors include Circassia Pharmaceuticals, Gimv, Quest for Growth, Entrepreneurs Fund, and Solon Ventures.